TY - JOUR
T1 - Role of Angiotensin Converting Enzyme-2 and its modulation in disease
T2 - exploring new frontiers
AU - Magazine, Rahul
AU - Chogtu, Bharti
AU - Bhat, Anup
N1 - Publisher Copyright:
© 2023, Medicine and Pharmacy Reports. All Rights Reserved.
PY - 2023
Y1 - 2023
N2 - Angiotensin Converting Enzyme-2 (ACE2), an important enzyme in the Renin Angiotensin Aldosterone System, degrades Angiotensin II (Ang II) into Angiotensin-(1-7) (Ang-(1-7)), whose actions are opposite to that of Ang II. Interestingly, SARS CoV-2 virus entry into human cells is mediated by ACE2. ACE2 receptors that are widely expressed in lungs and various other organs. Ang-(1-7) seems to have favorable effects on lungs, by preventing fibrosis in lung inflammation models, and exerts a similar action in cardiac and renal pathologies as well. Thus, modulation of Ang-(1-7) can be of potential benefit in chronic as well as acute inflammatory diseases affecting lungs and other organs. Upregulation of ACE2 by statins in different organs, and its consequent beneficial effects, have been demonstrated in many experimental studies, and also in a few clinical ones. This review aims at probing the role of ACE2 and its therapeutic modulation in pulmonary and extra pulmonary diseases, including COVID-19.
AB - Angiotensin Converting Enzyme-2 (ACE2), an important enzyme in the Renin Angiotensin Aldosterone System, degrades Angiotensin II (Ang II) into Angiotensin-(1-7) (Ang-(1-7)), whose actions are opposite to that of Ang II. Interestingly, SARS CoV-2 virus entry into human cells is mediated by ACE2. ACE2 receptors that are widely expressed in lungs and various other organs. Ang-(1-7) seems to have favorable effects on lungs, by preventing fibrosis in lung inflammation models, and exerts a similar action in cardiac and renal pathologies as well. Thus, modulation of Ang-(1-7) can be of potential benefit in chronic as well as acute inflammatory diseases affecting lungs and other organs. Upregulation of ACE2 by statins in different organs, and its consequent beneficial effects, have been demonstrated in many experimental studies, and also in a few clinical ones. This review aims at probing the role of ACE2 and its therapeutic modulation in pulmonary and extra pulmonary diseases, including COVID-19.
UR - http://www.scopus.com/inward/record.url?scp=85156233704&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85156233704&partnerID=8YFLogxK
U2 - 10.15386/mpr-2345
DO - 10.15386/mpr-2345
M3 - Review article
AN - SCOPUS:85156233704
SN - 2602-0807
VL - 96
SP - 146
EP - 153
JO - Medicine and Pharmacy Reports
JF - Medicine and Pharmacy Reports
IS - 2
ER -